This document outlines 6 predictions for the life sciences industry in 2018, including immunotherapies creating a new business model, augmented reality continuing to change healthcare provider engagement, risk-based approaches taking center stage, contract research organizations driving modernization of clinical environments, companies adopting standards to make engagement easier for shared customers, and combining applications to speed drug development. It directs the reader to a link for more details on Veeva's top predictions for the new year.

2. In 2018, the industry will accelerate
transformation across multiple functional
areas, including commercial, clinical,
regulatory, and quality. Find out what’s in
store for life sciences companies this year
with Veeva’s top predictions.

3. PREDICTION
Immunotherapies (i.e., CAR T-cell) will
create a new and inspiring business model
HENRY LEVY
#1

4. PREDICTION
Augmented reality (AR) will continue
to change HCP engagement
#2
ARNO SOSNA

5. PREDICTION
Risk-based everything (RBX) takes
center stage
#3
RICHARD YOUNG

6. PREDICTION
CROs will drive modernization of the
clinical environment across the industry
#4
HENRY LEVY

7. PREDICTION
Companies will adopt new industry
technology standards to make engagement
easier for shared customers
#5
PAUL SHAWAH

8. PREDICTION
Companies will bring together
applications across the development
lifecycle to speed drug development
#6
JEN GOLDSMITH

9. Discover more of Veeva’s
top predictions for the new year:
bit.ly/VeevaPredicts2018